Download Traitement
Transcript
Réponse PASI 75 à 1an 6/10 Pat. 5/10 Pat. 5/10 Pat. 6/10 Pat. 80 %patients PASI 75 60 61 % 56 % * 36 semaines 49 % 40 49 %* 45 %* 20 0 n = 45 Adalimumab1 40 mg/eow 1 x 80 mg induction n = 339 Efalizumab2 n = 193 n = 194 Etanercept3 25 mg n = 301 Infliximab4 50 mg→25 mg 5 mg/kg weekly 0, 2, 6; every 8 weeks BIW 1Gordon KB, et al. J Am Acad Dermatol. 2006;55 (4):598-606; 2Shear NH, et al. EADV 2005; FC13.15; 3Leonardi C, et al. AAD 2006; P2861; 4Reich K, et al. Lancet. 2005;366:1367-74 .